A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 150 participants.
Also called NCT04680026
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 150 participants
- Sponsor
- HUYABIO International, LLC.
- Registry
-
NCT04680026
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Bosnia & Herzegovina, Canada, New Zealand, Serbia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04680026. Randomized; quadruple masking; primary purpose treatment. Start 2021-06-01 (actual); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- HBI-3000
- Intervention (Drug)
- Placebo
- Lead sponsor
- HUYABIO International, LLC.
Record details
- Record id
cardio:ct-nct04680026- Content hash
d9e769c0930c3566acb0c70a3cc33b6a3ef819f9af044d75a3714c78e21ec293